Brain protection in arterial hypertension: what we have
- 00:00:05
Brain damage in hypertension
- 00:03:04
Chronic ischemia and microangiopathy
- 00:05:16
Early cognitive symptoms
- 00:07:32
The association of hypertension with cognitive impairment
- 00:08:49
Pressure and cognitive decline
- 00:14:24
MRI and hidden microinfarctions
- 00:19:21
Irreversibility of cognitive impairment
- 00:21:05
Mexidol as a cytoprotector
- 00:23:03
Confirmation of the effectiveness of Mexidol
- 00:37:38
Neuroprotection as a mandatory approach
Vadim Vitalievich Tyrenko , MD, Professor, Head of the Department of Faculty Therapy at the S.M. Kirov Military Medical Academy, Chief Cardiologist of the Russian Ministry of Defense, and Chief Pulmonologist of the Healthcare Committee of the Government of St. Petersburg.
Evgeniya Viktorovna Ekusheva , Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation at the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia.
Announcement:
As part of the "Interdisciplinary Academy. Neurology" series, a roundtable discussion was held on current issues in arterial hypertension. Experts—Professor Vadim Vitalyevich Tyrenko and Professor Evgeniya Viktorovna Ekusheva —discussed a key issue: how arterial hypertension damages the brain and leads to cognitive impairment.
What you will learn from the video:
- Hidden threats: why “silent” infarctions and leukoaraiosis are detected only by MRI;
- Early symptoms: how to recognize cognitive impairment before dementia develops;
- Treatment Errors: Why Blood Pressure Control Isn't Enough to Protect the Brain;
- Neuroprotection: clinical data on drugs with proven efficacy (including Mexidol);
- A cardiologist's advice: which antihypertensive drugs best protect cerebral blood vessels.
Watch the full analysis with evidence and clinical cases!
- 00:00:05
Brain damage in hypertension
- 00:03:04
Chronic ischemia and microangiopathy
- 00:05:16
Early cognitive symptoms
- 00:07:32
The association of hypertension with cognitive impairment
- 00:08:49
Pressure and cognitive decline
- 00:14:24
MRI and hidden microinfarctions
- 00:19:21
Irreversibility of cognitive impairment
- 00:21:05
Mexidol as a cytoprotector
- 00:23:03
Confirmation of the effectiveness of Mexidol
- 00:37:38
Neuroprotection as a mandatory approach